TKG Therapeutics
Developer of therapeutics for cancer patients. It offers Oncolytic Hairpin DNA Pair technology for development of immune-activating therapy that targets cancer cells with high miRNA expression. It induces innate immune activation, that targets the cGAS-STING pathway to kill cancer cells.